Atria Investments’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.95M | Sell |
7,511
-2,532
| -25% | -$1.42M | 0.04% | 466 |
|
|
2026
Q1 | $5.64M | Sell |
10,043
-750
| -7% | -$481K | 0.06% | 337 |
|
|
2025
Q4 | $7.3M | Buy |
10,793
+1,659
| +18% | +$1.13M | 0.08% | 266 |
|
|
2025
Q3 | $5.84M | Sell |
9,134
-696
| -7% | -$422K | 0.07% | 336 |
|
|
2025
Q2 | $5.27M | Buy |
9,830
+7,780
| +380% | +$3.72M | 0.06% | 366 |
|
|
2025
Q1 | $861K | Sell |
2,050
-380
| -16% | -$165K | 0.01% | 1068 |
|
|
2024
Q4 | $1M | Sell |
2,430
-709
| -23% | -$311K | 0.01% | 982 |
|
|
2024
Q3 | $1.59M | Sell |
3,139
-946
| -23% | -$460K | 0.02% | 751 |
|
|
2024
Q2 | $1.99M | Sell |
4,085
-464
| -10% | -$233K | 0.03% | 645 |
|
|
2024
Q1 | $2.46M | Buy |
4,549
+470
| +12% | +$257K | 0.03% | 577 |
|
|
2023
Q4 | $2.26M | Sell |
4,079
-80
| -2% | -$37.6K | 0.04% | 551 |
|
|
2023
Q3 | $1.82M | Sell |
4,159
-100
| -2% | -$49.9K | 0.03% | 602 |
|
|
2023
Q2 | $2.14M | Buy |
4,259
+396
| +10% | +$190K | 0.04% | 527 |
|
|
2023
Q1 | $1.93M | Sell |
3,863
-379
| -9% | -$181K | 0.04% | 545 |
|
|
2022
Q4 | $1.73M | Buy |
4,242
+286
| +7% | +$111K | 0.04% | 562 |
|
|
2022
Q3 | $1.29M | Buy |
3,956
+397
| +11% | +$146K | 0.03% | 630 |
|
|
2022
Q2 | $1.25M | Buy |
3,559
+14
| +0.4% | +$5.71K | 0.03% | 665 |
|
|
2022
Q1 | $1.94M | Buy |
3,545
+679
| +24% | +$357K | 0.03% | 584 |
|
|
2021
Q4 | $1.89M | Sell |
2,866
-266
| -8% | -$167K | 0.03% | 586 |
|
|
2021
Q3 | $1.95M | Sell |
3,132
-1,436
| -31% | -$965K | 0.04% | 542 |
|
|
2021
Q2 | $2.88M | Buy |
4,568
+357
| +8% | +$197K | 0.06% | 384 |
|
|
2021
Q1 | $2.06M | Sell |
4,211
-7,725
| -65% | -$3.87M | 0.05% | 440 |
|
|
2020
Q4 | $5.97M | Buy |
11,936
+7,533
| +171% | +$3.37M | 0.14% | 166 |
|
|
2020
Q3 | $1.73M | Buy |
4,403
+790
| +22% | +$292K | 0.05% | 382 |
|
|
2020
Q2 | $1.19M | Sell |
3,613
-262
| -7% | -$75.9K | 0.04% | 456 |
|
|
2020
Q1 | $939K | Buy |
3,875
+1,543
| +66% | +$403K | 0.07% | 235 |
|
|
2019
Q4 | $609K | Buy |
2,332
+942
| +68% | +$248K | 0.02% | 712 |
|
|
2019
Q3 | $378K | Sell |
1,390
-335
| -19% | -$93.2K | 0.01% | 650 |
|
|
2019
Q2 | $477K | Buy |
+1,725
| New | +$425K | 0.02% | 595 |
|
|
2018
Q4 | – | Sell |
-1,405
| Closed | -$351K | – | 943 |
|
|
2018
Q3 | $351K | Buy |
+1,405
| New | +$341K | 0.01% | 713 |
|
Other funds holding IDXX
Atria Investments's IDXX Position: Q2 2026 in Review
Atria Investments reduced its Idexx Laboratories (IDXX) stake by 25% in Q2 2026, selling an estimated $1.42M and leaving 7,511 shares worth $3.95M. The position accounts for 0.04% of the portfolio, ranked #466.
Atria Investments first reported a position in IDXX in Q3 2018 and has held it in 30 quarters since. The position peaked at $7.3M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Atria Investments held 7,511 shares of Idexx Laboratories worth $3.95M as of Q2 2026.
- Atria Investments sold 2,532 Idexx Laboratories shares in Q2 2026, an estimated $1.42M.
- Idexx Laboratories made up 0.04% of Atria Investments's portfolio in Q2 2026, its #466 holding.
- Atria Investments first reported a position in Idexx Laboratories in Q3 2018 and has held it in 30 quarters since.
- Atria Investments's Idexx Laboratories position peaked at $7.3M in Q4 2025.
- 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.